InKellyWeTrust
Well-known member
- Messages
- 2,955
- Reaction score
- 3,387
The HIV drug Leronlimab has shown great promise in treating moderate to severe Covid patients. Small sample, but no fatalities. Most patients were on oxygen or intubated at beginning of drug trial. Hearing about the drug out here in the West because that is where a good portion of tests are being conducted. Probably not getting the national exposure because it is not owned by a large company like Gilead or testing being conducted by Dr. Fauci like remdesivir.
https://finance.yahoo.com/news/cytodyn-reports-strong-results-eind-100010692.html
Sample size is the biggest issue. Need more data points. This is a very promising medication too. We discussed CCR5 inhibitors and BTK inhibitors earlier in this thread somewhere. There are many promising therapies. Nobody ever said the researchers are shutting up shop after the Remdesivir study. Also anything with "mab" in the name is a monoclonal antibody and pretty damn expensive to make - also a factor for widespread use.
I don't understand why everyone is so skeptical of the Fauci and the medical community at large having some sort of secondary gain from encouraging the use of Remdesivir. The study is large and shows pretty clear benefit. It is the only medication so far that has shown statistically significant benefit in a RCT sufficiently large, at least to my knowledge. Also, it was used mainly on patients with advanced disease. Most antivirals such as Remdesivir have greatest effect when used early in the disease course. So its easy to hypothesize even better outcomes when given earlier in disease course. One big issue with Remdesevir - it can only be given IV making it very difficult to use in the outpatient setting.